Isolyte M and 5% Dextrose Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Isolyte M and 5% Dextrose
C
- Caldolor (ibuprofen)
- Cambia (diclofenac)
- candesartan
- candesartan / hydrochlorothiazide
- Cap-Profen (ibuprofen)
- Capoten (captopril)
- Capozide (captopril / hydrochlorothiazide)
- Capozide 25 / 15 (captopril / hydrochlorothiazide)
- Capozide 25 / 25 (captopril / hydrochlorothiazide)
- Capozide 50 / 15 (captopril / hydrochlorothiazide)
- Capozide 50 / 25 (captopril / hydrochlorothiazide)
- captopril
- captopril / hydrochlorothiazide
- CaroSpir (spironolactone)
- Cataflam (diclofenac)
- Children's ElixSure IB (ibuprofen)
- Children's Motrin (ibuprofen)
- Childrens Ibuprofen Berry (ibuprofen)
- chlorpheniramine / ibuprofen / phenylephrine
- chlorpheniramine / ibuprofen / pseudoephedrine
- Clinoril (sulindac)
- clonidine / epinephrine / ketorolac / ropivacaine
- clonidine / ketorolac / ropivacaine
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Combogesic (acetaminophen / ibuprofen)
- Combogesic IV (acetaminophen / ibuprofen)
- Combunox (ibuprofen / oxycodone)
- Comfort Pac with Naproxen (naproxen)
- Cotrim (sulfamethoxazole / trimethoprim)
- Cotrim DS (sulfamethoxazole / trimethoprim)
- Cotrim Pediatric (sulfamethoxazole / trimethoprim)
- Coxanto (oxaprozin)
- Cozaar (losartan)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.